- Home
- SNY vs UBS Comparison
SNY vs UBS Comparison
Compare SNY & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNY | UBS |
|---|---|---|
| Founded | 1994 | 1862 |
| Country | France | Switzerland |
| Employees | 74846 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8B | 128.4B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | SNY | UBS |
|---|---|---|
| Price | $43.69 | $37.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $61.50 | $60.30 |
| AVG Volume (30 Days) | ★ 4.1M | 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.64% | 1.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.01 | $8.07 |
| Revenue Next Year | $5.80 | $3.47 |
| P/E Ratio | ★ $6.14 | $17.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.51 | $25.75 |
| 52 Week High | $59.17 | $49.36 |
Technical Indicators
Market Signals| Indicator | SNY | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 32.23 | 24.47 |
| Support Level | N/A | $37.41 |
| Resistance Level | $48.97 | $39.16 |
| Average True Range (ATR) | 0.68 | 0.81 |
| MACD | -0.36 | -0.17 |
| Stochastic Oscillator | 6.20 | 5.17 |
Price Performance
Historical ComparisonAbout SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About UBS UBS Group AG Registered
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.